E75.21 - Fabry (-Anderson) disease
| ICD-10: | E75.21 |
| Short Description: | Fabry (-Anderson) disease |
| Long Description: | Fabry (-Anderson) disease |
| Status: | Valid for Submission |
| Version: | ICD-10-CM 2023 |
| Code Classification: |
E75.21 is a billable ICD-10 code used to specify a medical diagnosis of fabry (-anderson) disease. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Angiokeratoma of skin
- Autonomic neuropathy due to Fabry disease
- Deficiency of alpha-galactosidase
- Fabry's disease
- Glomerular disease due to Fabry disease
- Glomerular disease due to neoplastic disease
Clinical Information
- Sphingolipidosis-. an inherited metabolic disorder that affects the metabolism of the spinhgolipids. representative examples include gaucher disease, tay-sachs disease, and niemann-pick disease.
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Anderson-Fabry disease - E75.21
- - Angiokeratoma - See: Neoplasm, skin, benign;
- - corporis diffusum - E75.21
- - Degeneration, degenerative
- - brain (cortical) (progressive) - G31.9
- - in
- - Fabry-Anderson disease - E75.21
- - in
- - brain (cortical) (progressive) - G31.9
- - Disease, diseased - See Also: Syndrome;
- - Sweeley-Klionsky - E75.21
- - Disorder (of) - See Also: Disease;
- - glomerular (in) - N05.9
- - Fabry's disease - E75.21
- - glomerular (in) - N05.9
- - Fabry (-Anderson) disease - E75.21
- - Glomerulonephritis - See Also: Nephritis; - N05.9
- - in (due to)
- - Fabry (-Anderson) disease - E75.21
- - in (due to)
- - Lipidosis - E75.6
- - glycolipid - E75.21
- - Sweeley-Klionsky disease - E75.21
Convert to ICD-9 Code
| Source ICD-10 Code | Target ICD-9 Code | |
|---|---|---|
| E75.21 | 272.7 - Lipidoses | |
| Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. | ||
Patient Education
Genetic Brain Disorders
A genetic brain disorder is caused by a variation or a mutation in a gene. A variation is a different form of a gene. A mutation is a change in a gene. Genetic brain disorders affect the development and function of the brain.
Some genetic brain disorders are due to random gene mutations or mutations caused by environmental exposure, such as cigarette smoke. Other disorders are inherited, which means that a mutated gene or group of genes is passed down through a family. They can also be due to a combination of both genetic changes and other outside factors.
Some examples of genetic brain disorders include:
- Leukodystrophies
- Phenylketonuria
- Tay-Sachs disease
- Wilson disease
Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain development and function. These brain disorders can cause serious problems that affect the nervous system. Some have treatments to control symptoms. Some are life-threatening.
[Learn More in MedlinePlus]
Fabry disease
Fabry disease is an inherited disorder that results from the buildup of a type of fat, called globotriaosylceramide, in the body's cells. Beginning in childhood, this buildup causes signs and symptoms that affect many parts of the body. Characteristic features of Fabry disease include episodes of pain, particularly in the hands and feet (acroparesthesias); clusters of small, dark red spots on the skin called angiokeratomas; a decreased ability to sweat (hypohidrosis); cloudiness or streaks in the front part of the eye (corneal opacity or corneal verticillata); problems with the gastrointestinal system; ringing in the ears (tinnitus); and hearing loss. Additional signs and symptoms are possible, which can vary among affected individuals.
Fabry disease also involves potentially life-threatening complications such as progressive kidney failure, heart failure, and stroke. Some affected individuals have milder forms of the disorder that appear later in life and typically involve only the heart, kidneys, or blood vessels in the brain.
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
